Citation Impact
Citing Papers
Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression
2019 Standout
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Overexpression of VEGF-C correlates with a poor prognosis in esophageal cancer patients
2016
Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging
2005 StandoutNobel
Molecular imaging in drug development
2008 Standout
Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer
2013
Fertilisers production from ashes after sewage sludge combustion – A strategy towards sustainable development
2017 Standout
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
Sentinel Lymph Node Mapping With Type-II Quantum Dots
2007 StandoutNobel
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
The Future of Cancer Imaging
2002
The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis
2008
Image-Guided Oncologic Surgery Using Invisible Light: Completed Pre-Clinical Development for Sentinel Lymph Node Mapping
2006 StandoutNobel
Extraction of raw sewage sludge containing iron phosphate for phosphorus recovery
2012
Pancreatic cancer
2020 Standout
Tumor metastasis and the lymphatic vasculature
2009
Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection
2004
Drug penetration in solid tumours
2006 Standout
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
PD-1/PD-L1 and immunotherapy for pancreatic cancer
2017
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Reduced local immune response with continuous positive airway pressure during one-lung ventilation for oesophagectomy
2014
Microenvironmental and cellular consequences of altered blood flow in tumours
2003
Molecular mechanisms of cisplatin resistance
2011 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial
2020
Nuclear Transfer to Eggs and Oocytes
2011 StandoutNobel
Peritoneal Carcinomatosis of Colorectal Origin
2006
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]‐2‐fluro‐2‐deoxy‐d ‐glucose positron emission tomography
2008
Nuclear reprogramming in eggs
2009 StandoutNobel
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Control of DNA replication and its potential clinical exploitation
2005
Systems biology of cisplatin resistance: past, present and future
2014
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Epstein-Barr virus and gastric carcinoma
2000
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer
2006
Gastric cancer
2020 Standout
The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON
2006
Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis
2005
Cisplatin: The first metal based anticancer drug
2019 Standout
Molecular mechanisms of carbonic anhydrase IX‐mediated pH regulation under hypoxia
2008 StandoutNobel
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
[18F]Fluorodeoxyglucose Uptake in Recurrent Thyroid Cancer Is Related to Hexokinase I Expression in the Primary Tumor
2005
Lymphatic Drainage of the Peritoneal Space: A Pattern Dependent on Bowel Lymphatics
2006 StandoutNobel
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Evolving options in the management of esophageal perforation
2004 Standout
Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer
2012
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial
2015
Performance of double-layer biofilter packed with coal fly ash ceramic granules in treating highly polluted river water
2012
Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3−/− mice
2006
Young-onset colorectal cancer
2023
Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies
2007
Meta-analysis
2011
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Altered ErbB Receptor Signaling and Gene Expression in Cisplatin-Resistant Ovarian Cancer
2005
Review of sewage sludge management: standards, regulations and analytical methods
2014 Standout
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers
2009 Standout
The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment
2006
MCM Paradox: Abundance of Eukaryotic Replicative Helicases and Genomic Integrity
2014
A comprehensive review on the applications of coal fly ash
2014 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
The extracellular matrix at a glance
2010 Standout
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Combination therapy in combating cancer
2017 Standout
Engineering InAsxP1-x/InP/ZnSe III−V Alloyed Core/Shell Quantum Dots for the Near-Infrared
2005 StandoutNobel
18F-FDG PET/CT Imaging In Oncology
2011
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
2005
Regulation of cell proliferation by hypoxia-inducible factors
2015 StandoutNobel
Epidemiology of gastric cancer
2006 Standout
Molecular epidemiology, pathogenesis and prevention of gastric cancer
1999
Association of Timing of Adjuvant Therapy With Survival in Patients With Resected Stage I to II Pancreatic Cancer
2019
Temperature-, gate-, and photoinduced conductance of close-packedCdTe
2006 StandoutNobel
Microregional Expression of Glucose Transporter-1 and Oxygenation Status: Lack of Correlation in Locally Advanced Cervical Cancers
2005
Works of Hitoshi Ojima being referenced
Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
2003
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
2016
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma
2004
Sentinel lymph nodes with technetium‐99m colloidal rhenium sulfide in patients with esophageal carcinoma
2003
Successful late management of spontaneous esophageal rupture using T-tube mediastinoabdominal drainage
2001
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer
2006
An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma
2004
Interferon-γ and granulocyte colony-stimulating factor in bronchoalveolar lavage fluid after oesophagectomy
2004
A randomized phase II study of combination therapy with S-1, oral leucovorin, and oxaliplatin (SOL) and mFOLFOX6 in patients with previously untreated metastatic colorectal cancer
2015
A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma
2003
Development of an advanced biological treatment system applied to the removal of nitrogen and phosphorus using the sludge ceramics
2005
Expression of nitrotyrosine is associated with angiogenesis in esophageal squamous cell carcinoma.
2002
Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer.
2008
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
2021
Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
2005
Utility of serosal stamp cytology as an indicator for high-risk peritoneal metastasis in colorectal cancer surgery.
2003
Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas.
2006
Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.
2003
Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma
2002
Infrequent Overexpression of p53 Protein in Epstein‐Barr Virus‐associated Gastric Carcinomas
1997